N
DRIO icon

Nuveen’s DarioHealth DRIO Stock Holding History

Nuveen’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,295
Closed -$298K – 3309
2022
Q1 		$298K Buy
2,295
+3
+0.1% +$496 ﹤0.01% 3123
2021
Q4 		$614K Sell
2,292
-305
-12% -$92.8K ﹤0.01% 3012
2021
Q3 		$747K Buy
2,597
+90
+4% +$26K ﹤0.01% 3086
2021
Q2 		$1.07M Buy
+2,507
New +$955K ﹤0.01% 2980

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's DRIO Position: Q2 2022 in Review

Nuveen sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 2,295 shares — an estimated $298K sold.

Nuveen first reported a position in DRIO in Q2 2021 and held it in 4 quarters. The position peaked at $1.07M in Q2 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Nuveen reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 2,295 DarioHealth shares in Q2 2022, an estimated $298K.
  • Nuveen first reported a position in DarioHealth in Q2 2021 and held it in 4 quarters.
  • Nuveen's DarioHealth position peaked at $1.07M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.